Novel work from graduate student team of Michael Sturdivant and Andrew Truong is published in Nature Communications! Their work demonstrates that APOBEC3A promotes squamous transdifferentiation through IL1A, which is a highly targetable pathway. We hope that inhibiting squamous transdifferentiation may aid in the prevention of therapeutic resistance.